Download AbbVie Responsible Business Prospectus: Ireland

THE ROAD AHEAD
Our commitment to
responsible business practices
COMMITTED TO OUR RESPONSIBILITY
In Ireland and around the world, AbbVie is committed
to having a remarkable impact on people’s lives. A
simple statement perhaps, but think about what that
means: to have a truly remarkable impact means that
we must strive to be remarkable in all we do.
We do this by listening to changing patient needs, looking
and thinking ahead, and constantly innovating. By innovating
our product offerings, educating our patients, supporting our
healthcare professionals and increasing access to care, this
remarkable impact is happening right now, all around us.
Our remarkable impact is not limited to our
customers. We pledge to be a responsible corporate
citizen, mindful of our responsibilities to our
people, our communities and our environment.
AbbVie Ireland has developed a vision of responsible
business. We are developing an ethical business culture,
a sustainable supply chain and a responsible approach to
research. We are working with our employees to engage
them with this vision. We are advancing responsible research
and believe in delivering exemplary ecological stewardship.
AbbVie Ireland is committed to communicating openly
and clearly with you, our stakeholders. This commitment
begins with this booklet, which sets out the road ahead
towards sustained responsible business practice.
This booklet signals our intent to live up to our
responsibilities to our people, our communities and our
environment in an open, transparent and consistent way.
We will introduce you to our new company and its strong
heritage. We will demonstrate the unwavering focus we
have on helping the patients who rely on us to reach their
highest potential. We will introduce you to AbbVie in
Ireland, demonstrating our commitment to the country
and its people. And we will outline how we will make a
real difference through our approach to corporate social
responsibility here in Ireland, and how we will measure and
share our performance through our annual report card.
Young Social Innovators is a youth organisation that believes
in the power of young people to bring about change in their
communities. It focuses on empowering young people
through education for social innovation. AbbVie embarked
on a pioneering programme with the charity to run a series
of EXPLORE Social Innovation Workshops in Dublin, Sligo
and Cork schools. These workshops are tailored to ignite
the creativity of 15 to 18 year olds and empower them
to recognise their potential to make a positive difference
to their lives, the lives of others and to wider society.
THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE
COMMITTED TO OUR RESPONSIBILITY1
ABOUT ABBVIE
HU
MA
RE
SO N
UR
CE
S
CO
INV MM
OL UNI
VE
ME TY
NT
PATIENTS
IAL
RC
ME ONS
M
CO RATI
E
OP
VA
L
UE
CH
AIN
BORATI
ON
LLA
CO
AbbVie has an absolute commitment to the patient. We
draw on our deep expertise in some of the most difficultto-treat diseases to deliver hope to those in need. We
seek to understand all aspects of a patient’s journey
with their illness so that we are better equipped to find
solutions. This patient-centred approach to discovery
and development helps ensure we remain focused on
the task of improving lives as we seek to make the most
positive impact possible on the health of society.
H&
RC NT
E
SEA
RE OPM
L
VE
E
D
CE
PATIENT-CENTRED
TER
AF NAL
FAI
RS
AN
AbbVie produces a range of products and we have many
more in development. These are targeted at complex
and difficult-to-treat areas. In Ireland, our company
markets treatments for advanced Parkinson’s disease
and a medicine to prevent respiratory infections that
can have very serious consequences for the health of
premature and vulnerable infants. Other AbbVie products
licensed here help those with a wide range of immunemediated conditions including rheumatoid arthritis,
Crohn’s disease, ulcerative colitis, and psoriasis.
EX
FIN
AbbVie was founded in 2013 when Abbott, a proven
healthcare leader with a 125-year heritage of achievement,
was separated into two publicly listed companies. The
outcome was a new organisation called AbbVie that
retained the expertise and world-wide reach of a proven
industry achiever, but also displayed the focus, passion
and innovation of a newly-established enterprise.
Y
EG
AT
AbbVie’s nurse-led service allows treatment of premature
infants to take place in the home setting
Research and innovation are the cornerstones of AbbVie’s
business as a global biopharmaceutical company. Our
work in this area focuses on developing medicines that
deliver strong clinical performance, provide more patient
benefit and offer economic value, particularly where
there is significant need in certain disease areas.
STR
THE HISTORY OF A NEW BEGINNING
RESEARCH AND INNOVATION
OVATION
INN
AbbVie is a global, research-based biopharmaceutical company. Our 25,000 people – including more
than 400 based in Ireland – move science forward by applying a unique approach to innovation,
developing advanced medicines and marketing our products in more than 170 countries. Aiming to
have a remarkable impact on patients, we take on today’s most complex and challenging diseases.
We use collaboration and innovation to put
patients at the centre of everything we do.
One of AbbVie’s medicines is administered to vulnerable infants to help protect them from
Respiratory Syncytial Virus or RSV, a leading cause of bronchiolitis and pneumonia during the
winter months. Synacare is a service provided by AbbVie which involves a qualified paediatric
nurse travelling to the family home and administering the preventative treatment each
month during the RSV season. This means these young patients are kept away from crowded
waiting rooms where they are at risk of contracting RSV and other winter infections.
Since it started in 2008, over 4,000 infants and their families have benefited from the service
which has removed more than 18,500 appointments from the hospital system.
2
THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE
ABOUT ABBVIE3
ABBVIE IN IRELAND
ABBVIE CORK
ABBVIE SLIGO
AbbVie Ireland operates two separate plants
in Sligo employing more than 200 staff. The
company’s high containment facility on
the Manorhamilton Road was established
in 2002 and has dedicated capabilities for
potent active pharmaceutical ingredient
and drug product manufacturing.
AbbVie Sligo
Manorhamilton Road
The quality control labs are equipped with
the latest design technology for chemical and
microbiological analytical testing to meet
customers’ needs. This site recently underwent
a significant €85 million expansion that doubled
its footprint and provided additional capability
to support AbbVie’s new product introductions.
AbbVie has a second manufacturing site in
Sligo at Ballytivnan. Founded in 1974, this
plant is now a global centre of excellence for
design control and precision engineering in
the production of drug delivery devices.
AbbVie Dublin
Liffey Valley
ABBVIE DUBLIN
The company’s commercial offices
are located at the Liffey Valley
Office Campus in Quarryvale, west
Dublin. More than 70 people work
here overseeing the sale, supply,
distribution and marketing of the
company’s Irish-licensed products.
AbbVie’s Medical Director and Irish
support team work from this site.
AbbVie Sligo
Ballytivnan
A second office at Woodford Business
Park, Santry, north Dublin is an
international base for a range of AbbVie
manufacturing and engineering services.
These support company plants all
around the world. The office is a key
base for senior management, finance,
engineering, quality assurance (QA),
programme management, projects and
packaging, engineering, environmental
health services, talent acquisition,
purchasing and development processes.
Among the products made at this location
are components for a pen-style device used
by patients who have been prescribed a
company treatment for rheumatoid arthritis,
Crohn’s disease, psoriasis and other immune
mediated inflammatory conditions.
The treatment can be delivered via a syringe or
our pen device but 70% of patients surveyed
preferred this latter option, showing how we
use patients’ needs to drive our innovation.
4
Our plant in Carrigtwohill, on the
outskirts of Cork, is a modern ‘bulk
tablet’ finish facility which manufactures
solid and capsule formulations.
Innovative new technologies, in
combination with the depth of
expertise that exists within the local
workforce, allow those based there
to develop and deliver products
and processes to support AbbVie’s
wider global needs. These range from
small scale clinical trial supply to
large commercial manufacturing.
AbbVie Cork
Carrigtwohill
THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE
AbbVie Dublin
Santry
ABBVIE IN IRELAND5
OUR CORPORATE SOCIAL
RESPONSIBILITY FRAMEWORK
FOUR UNIQUE OPPORTUNITIES TIED TO OUR FRAMEWORK FOR CHANGE
AbbVie’s corporate responsibility framework has been structured to allow us to deliver on four unique
opportunities: our environment, our community, our workplace and our marketplace.
We are committed to supporting patients as they make their journey through the continuum of care in order
to improve health outcomes. We utilise the potential of advanced science by leveraging the expertise of our
people to address global health needs, improve outcomes and raise standards, all while building health system
capacity and increasing access to care. And we are committed to maintaining our role as a global philanthropic
leader4 dedicated to transforming education and narrowing the achievement gap in science and literacy.
ENVIRONMENT
Optimally managing
the world’s limited
resources is a key business
responsibility and AbbVie
understands that efficient
environmental strategies
are crucial to ensure this.
6
THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE
COMMUNITY
We recognise that building
trust and reputation in
our communities is also
essential to the long-term
sustainability of our business.
WORKPLACE
In the workplace, AbbVie
is committed to building
the capability of our
employees by developing
their skills to help them
reach their full potential.
MARKETPLACE
AbbVie is committed to
ethical business practices
in the marketplace
and we strive to meet
the highest levels of
professional standards.
OUR CORPORATE SOCIAL RESPONSIBILITY FRAMEWORK7
SOME EXAMPLES OF WHAT
WE’VE ACHIEVED TO DATE
ENVIRONMENT
„„ AbbVie Ireland in Sligo achieved a 14% reduction in
CO2 emissions over the period 2010-2012 versus
a target of 12%. The Manorhamilton Road plant
installed a low pressure hot water energy (LPHW)
building heating system that will reduce the site’s CO2
emissions by 572 tonnes and deliver significant annual
savings. This energy project won an AbbVie Global
Environmental Health and Safety award for 2013.
„„ A new AbbVie solution for GPs struggling to find time
to attend educational meetings is also delivering an
environmental benefit. Dr Robert Coughlan, a Galwaybased consultant rheumatologist, has organised a
continuing series of highly-successful online seminars for
GPs. The online seminar saved approximately 445,220km
of travel, equating to approximately 31,801 litres of
fuel. AbbVie also sends all certificates of attendance
(860 pages to date) and training materials (4,300 pages
so far) electronically via email to each attendee, saving
trees and contributing to a greener environment.
„„ All three AbbVie manufacturing sites hold an ISO 14001
Environment Management Services Certificate whilst
Cork has been awarded an ISO 50001, an international
standard for energy management which provides a
robust framework for optimising energy efficiency.
8
COMMUNITY
„„ AbbVie encourages its workforce to actively
support worthy community causes and Irish-based
employees volunteered over 1,700 hours last year in
partnerships with charities, hospitals and schools.
„„ AbbVie and its employees made donations
and raised funds for a range of causes last year
including the new Cardiology Ward at Our Lady’s
Hospital for Sick Children in Crumlin, the Irish
Cancer Society, the Irish Blood Transfusion
Service and the North West Hospice.
„„ AbbVie has partnered with Young Social Innovators
to enable this highly respected charity run a series of
school workshops across the country. These speciallydesigned events encourage teenagers to consider
harnessing their unique creative potential by playing an
active role in addressing societal issues that affect them
and their peers. The work of Young Social Innovators
has played a leading role in demonstrating how Irish
students can deliver vital change on a wide range
of issues from cyber bullying and health awareness
to animal welfare and social inclusion. AbbVie
volunteers have assisted in delivering workshops at
almost twenty schools in Sligo, Dublin and Cork.
THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE
WORKPLACE
„„ Our company is committed to creating opportunities
to innovate, collaborate and demonstrate excellence
every day. We offer numerous career paths to help our
people succeed in our many businesses and functions,
including research and development, technology,
finance, operations, regulatory affairs and compliance,
medical affairs, sales, marketing, human resources and
more. Last year across AbbVie’s sites in Ireland this
commitment to developing our people was brought
to life with 15% of our employees moving to the
next level in their career through a promotion.
„„ The key defining feature of a great workplace is the
level of trust that exists within it. For employees, a
great workplace is one where you trust the people
you work with, you have great pride in what you do,
and you enjoy the people you work with. The Great
Place to Work Institute assesses the policies and
practices in place in organisations. It then benchmarks
these against other organisations in each country. The
Institute conducts an anonymous ‘Trust Index Survey’
that gathers the employees’ views. Finally, there is an
in-depth qualitative analysis of open ended comments
from employees. AbbVie entered this competition for
the first time in 2014 and the judges selected it among
the Top 20 Best Large Workplaces in Ireland.2
MARKETPLACE
„„ Our AbbVie Code of Business Conduct, published
in print and online in 32 different languages, sets out
core guidance and requirements in this regard. Our
employees read and certify this code annually.
AbbVie expects its business partners, including
contract workers, vendors, suppliers and consultants,
to adhere to ethical behaviour within the spirit of
this code, and to also observe all applicable laws
and regulations when working on our behalf.
„„ When it comes to innovation, AbbVie starts with the
patients. This often involves delivering value beyond
the medicine. One of the ways we do this is by assisting
patient organisations such as Move4Parkinson’s, a
remarkable charity which harnesses the power of
singing to life-changing effect. Mags Mullarney of
Move4Parkinson’s said, “AbbVie has made resources
available…which support people with Parkinson’s
and helps them to have a better quality of life.
However, perhaps even more important has been the
support that AbbVie and its employees have offered
members of Move4Parkinsons and their families
at a human level in terms of genuine interest, care,
respect and understanding. We believe AbbVie truly
understands the meaning of patient engagement.”
SOME EXAMPLES OF WHAT WE’VE ACHIEVED TO DATE9
GLOBAL ABBVIE EXAMPLES
OF OUR CORPORATE
RESPONSIBILITY APPROACH
AbbVie aims to have a remarkable impact on patients’ lives at a local and global level. We
try to achieve this as a sustainable business, as a responsible corporate citizen, and as a
philanthropic leader. Corporate responsibility efforts are focused on our unique opportunities
to support patients, build capacity, leverage expertise and transform education.
SUPPORT PATIENTS
In 2013, more than 100 of AbbVie’s most experienced
scientists contributed their expertise to helping solve
NTDs through drug development projects, advisory
boards and compound screening partner organizations.
AbbVie has provided over 100,000 of our compounds
for screening against diseases like tuberculosis.
TRANSFORM EDUCATION
As a new company, we’re just beginning our journey to impact
education. We’re focusing on narrowing the achievement
gap in science and literacy. We’re making a difference in
education in our local communities – and around the world.
AbbVie is proud of our long-term partnership with the
Asian University for Women based in Bangladesh that aims
to educate a new generation of leaders in Asia. AbbVie
scientists provide weekly lectures via video conference
to 25 senior level science students at the university.
We support the patient journey through the continuum
of care to improve health outcomes. Innovative patient
programmes meet patients’ needs around the world. The
AbbVie Foundation’s Global AIDS Care Programme has
reached more than six million children and families, donated
more than 24 million HIV rapid tests and invested more
than $275 million to combat AIDS in the developing word.
BUILD CAPACITY
AbbVie partners and collaborates with others to build health
system capacity and infrastructure in order to increase access
to care. AbbVie and the AbbVie Foundation provided more
than $1.5 million in critically-needed product donations
and $550,000 in cash grants to respond to disasters in
2013. We partner with leading organisations, such as the
Baylor College of Medicine Pediatric AIDS Initiative, which
we’ve supported to build paediatric HIV clinics first in
Romania and then replicated in Malawi and Tanzania.
LEVERAGE EXPERTISE
AbbVie aims to leverage our expertise and resources
to address global health needs and improve standards
of care. AbbVie is committed to addressing and solving
10
In 2014, the AbbVie Foundation will launch a new science
education programme delivered by AbbVie employees
globally. Ireland is the first country to launch this new
programme in primary schools in Dublin, Cork and Sligo.
The AbbVie Foundation’s long-term partnership with AMPATH in
Kenya currently helps support the care and treatment of 160,000 HIV
patients. This is part of the AbbVie Global AIDS Care program that
has reached more than six million patients in the past ten years.
the world’s recognised health challenges, including
Neglected Tropical Diseases (NTDs). NTDs are a
group of infections that disproportionately impact the
world’s poor and marginalised populations. According
to the World Health Organisation, more than one billion
people suffer from one or more of these conditions.
THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE
RESPONSIBLE BUSINESS FOCUS GLOBALLY
„„ Ethical culture: Our interactions with healthcare
professionals are meant to impact patient care
and are guided by openness and transparency.
„„ Responsible research: We engage in responsible
research practices that respect patients.
„„ Engaged employees: In 2014, AbbVie is launching
a new program called ‘Possibilities 365’ to facilitate
employees’ volunteering and giving efforts globally.
Ireland is a global pilot for this new programme due
to employees’ commitment to their communities.
„„ Healthy environment: AbbVie aims for 20% reduction
in carbon as CO2e total water intake and total waste
disposal by 2020 (normalized by sales and over a
2013 baseline). In addition, we aim to reduce AbbVie’s
recordable incidents 20% by 2020 (absolute number).
„„ Sustainable supply chain: In 2013, AbbVie’s first
annual Supplier Sustainability Survey found 23%
of key suppliers to be sustainable. Our goal is to
work with key suppliers so that 50% are designated
sustainable in 2014, and 100% by 2017.
„„ Strategic philanthropy: AbbVie and AbbVie’s
foundations’ 2013 grants and charitable
donations were more than $905 million.
Since the pursuit of possibility takes root at a young
age, AbbVie supports the Kohl Children’s Museum’s
travelling science laboratory exhibit to encourage an
interest in science among students. More than 9,500
children and families visited the exhibit when it was
on display in Brazil in 2013. AbbVie employees also
volunteered at the exhibit to conduct activities for children,
sharing their love of science with the young visitors.
GLOBAL ABBVIE EXAMPLES OF OUR CORPORATE RESPONSIBILITY APPROACH11
MEASURING UP TO OUR COMMITMENTS
AbbVie is a new company and although we have
only just begun our corporate responsibility journey,
we have already managed a number of notable
achievements. We’ve received a prestigious Western
Europe Region Corporate Energy Management Award1
from the Association of Energy Engineers. We have
entered a partnership with the charity Young Social
Innovators to encourage young adults to play their
vital role in helping to improve our society3. And we
have been voted one of Ireland’s best places to work.
But there is much yet to do…
COMMUNICATIONS AND GOVERNANCE
As a new company steeped in a century-long
tradition of responsibility, AbbVie is committed to
improving lives and we pledge to go about it in a
transparent way. We plan to replicate the openness
and accountability that is a hallmark of our company’s
financial reporting in the way we communicate our
corporate social responsibility activity in Ireland.
Good communication goes hand-in-hand with good
governance and we intend to make a documented
commitment to assessing responsible business
practices across all aspects of our business. We
will do this by undertaking and publishing an
annual responsible business audit. This document
will report on and measure our performance
as a company in this sphere of activity.
12
THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE
THE ABBVIE REPORT CARD
In 2015, the AbbVie Report Card will establish the company’s
performance across a range of responsible business priorities.
Each year we will assess how we measured up to our
commitments and set new goals for improving our results.
The AbbVie Responsible Business Report Card will help us to:
„„ Measure our environmental impact in areas
such as energy use, water intake, waste
disposal and recycling and set environmentally
sustainable targets across all Irish sites
„„ Define, explain and demonstrate our commitment
to the local communities in which we work
„„ Facilitate analysis and improvement of
workplace standards ranging from personal and
career development opportunities to delivering
accident-free working environments
„„ Ensure the company does all it can to promote
responsible business behaviours in the
marketplace, including maintaining continuity
of supply and improving supplier standards
The AbbVie Report Card will provide
us with an opportunity to define our
company’s approach to responsible
business with our stakeholders in a
transparent manner. We will circulate it
to our people and to wider society. In this
way, we will ensure that our responsible
business performance is measured against
a series of publicly defined priorities at a
local, national and international level.
MEASURING UP TO OUR COMMITMENTS13
ENVIRONMENT
COMMUNITY
WORKPLACE
MARKETPLACE
For further information on the company and its people,
portfolio and commitments, please contact:
Robert Love (Head of Communications)
AbbVie Limited
Block B, Liffey Valley Office Campus, Quarryvale, Co. Dublin
Telephone: 01 428 7900
Email: [email protected]
References: 1. Association of Energy Engineers (AEE) Western Europe
Region Corporate Energy Management Award, 2012. 2. AbbVie
came 16th in the Great Places to Work Ireland rankings in 2013. 3.
AbbVie ‘Schools Innovation Workshop’ partnership with YSI, 2013.
Date of Preparation: August 2014 | IRECOR140171
This booklet is printed on 100% recycled paper